Yet another recall by Johnson & Johnson (JNJ -0.9%), this time for ~200,000 syringes of its...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Yet another recall by Johnson & Johnson (JNJ -0.9%), this time for ~200,000 syringes of its Eprex anemia drug in the U.K., Canada and 15 other countries after internal testing revealed some batches of the drug were less potent than necessary. A string of recalls has cost JNJ an estimated $1.9B in lost sales during 2010-11.